|Jmol-3D images||Image 1|
|Molar mass||195.26 g/mol|
|Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)|
|(what is: / ?)|
4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a mescaline analogue related to other psychedelic phenethylamines. It is commonly referred to as DESOXY. DESOXY was discovered by Alexander Shulgin and published in his book PiHKAL.
The effects of DESOXY vary significantly from mescaline, despite their chemical similarity. Users report an elevated mood and some hallucinations, although nothing as intense as visuals reported on mescaline. There has been some suggestion that the dosage level of 40-120 mg might be too small to achieve mescaline-like effects, but since this compound has undergone only limited human experiments it may be unsafe to increase the dosage.
A typical dosage is within the range of 40-120 mg and lasts 6–8 hours.
In 1970 the Controlled Substances Act placed mescaline into Schedule I in the United States. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an analogue of mescaline, under the Federal Analogue Act and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.
- Alexander Shulgin, Jacob, P. Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs. NIDA Research Monograph 146 (Hallucinogens: An Update), 1994.